Paramesh Shamanna
YOU?
Author Swipe
View article: SAT-538 Improvement In Glycemic Control And Cardiometabolic Parameters With Digital Twin Technology: Outcomes Of RCT At 2 Years
SAT-538 Improvement In Glycemic Control And Cardiometabolic Parameters With Digital Twin Technology: Outcomes Of RCT At 2 Years Open
Disclosure: S.R. Joshi: Novo Nordisk, Twin Health, USV, Zydus Lifesciences, Franco Indian, Glenmark, Marico, Sanofi, Abbott Laboratories, Eli Lilly & Company, Lupin, Bayer Zydus, Alkem, Alembic, DRL, Meyer Organics, Universal Nutrisciences…
View article: OR20-07 Digital Twin Technology For T2D Remission And ASCVD Risk Reduction: 2-Year RCT Outcomes
OR20-07 Digital Twin Technology For T2D Remission And ASCVD Risk Reduction: 2-Year RCT Outcomes Open
Disclosure: S.R. Joshi: Novo Nordisk, USV, Twin Health, Zydus Lifesciences, Franco Indian, Glenmark, Marico, Abbott Laboratories, Sanofi, Eli Lilly & Company, Lupin, Bayer Zydus, Alkem, Alembic, DRL, Meyer Organics, Universal Nutrisciences…
View article: Digital Twin Technology in Resolving Polycystic Ovary Syndrome and Improving Metabolic Health: A Comprehensive Case Study
Digital Twin Technology in Resolving Polycystic Ovary Syndrome and Improving Metabolic Health: A Comprehensive Case Study Open
This case highlights the potential of DT technology in managing PCOS, showing significant metabolic and reproductive improvements, suggesting promising future research directions.
View article: Personalized nutrition in type 2 diabetes remission: application of digital twin technology for predictive glycemic control
Personalized nutrition in type 2 diabetes remission: application of digital twin technology for predictive glycemic control Open
Background Type 2 Diabetes (T2D) is a complex condition marked by insulin resistance and beta-cell dysfunction. Traditional dietary interventions, such as low-calorie or low-carbohydrate diets, typically overlook individual variability in …
View article: One-year outcomes of a digital twin intervention for type 2 diabetes: a retrospective real-world study
One-year outcomes of a digital twin intervention for type 2 diabetes: a retrospective real-world study Open
This retrospective observational study, building on prior research that demonstrated the efficacy of the Digital Twin (DT) Precision Treatment Program over shorter follow-up periods, aimed to examine glycemic control and reduced anti-dia…
View article: 12524 Predictive Factors For Type 2 Diabetes Remission: Insights From A Digital Twin Intervention Program At 18 Months
12524 Predictive Factors For Type 2 Diabetes Remission: Insights From A Digital Twin Intervention Program At 18 Months Open
Disclosure: P. Shamanna: None. M. Dharmalingam: None. A. Vadavi: None. A. Keshavamurthy: None. S. Bhonsley: None. M. Thajudeen: None. A. Balasubramanian: None. S.R. Joshi: None. Background and aims: Digital twin (DT) platform uses Artifici…
View article: 8814 Concordance in Defining Diabetes Remission: A Comparative Analysis of HbA1c, eA1c, and FPG Criteria After One Year of Digital Twin (DT) Intervention
8814 Concordance in Defining Diabetes Remission: A Comparative Analysis of HbA1c, eA1c, and FPG Criteria After One Year of Digital Twin (DT) Intervention Open
Disclosure: P. Shamanna: None. M. Dharmalingam: None. A. Vadavi: None. A. Keshavamurthy: None. S. Bhonsley: None. M. Thajudeen: None. A. Balasubramanian: None. S.R. Joshi: None. Introduction: This study investigates the concordance among H…
View article: 12600 Predictors Of Diabetes Remission: The Impact Of Early Intervention Through A Digital Twin Platform
12600 Predictors Of Diabetes Remission: The Impact Of Early Intervention Through A Digital Twin Platform Open
Disclosure: S.R. Joshi: None. M. Dharmalingam: None. A. Vadavi: None. A. Keshavamurthy: None. S. Bhonsley: None. M. Thajudeen: None. A. Balasubramanian: None. M. Panandikar: None. P. Shamanna: None. Introduction and Objective: Digital twin…
View article: Digital Twin in Managing Hypertension Among People With Type 2 Diabetes
Digital Twin in Managing Hypertension Among People With Type 2 Diabetes Open
Artificial intelligence -enabled DT technology is more effective than SC in reducing BP and anti-HTN medications and inducing HTN remission and normoalbuminuria in participants with HTN and T2D. (A Novel WholeBody Digital Twin Enabled Prec…
View article: One-Year Outcomes of a Digital Twin Intervention for Type 2 Diabetes: A Retrospective Real-World Study
One-Year Outcomes of a Digital Twin Intervention for Type 2 Diabetes: A Retrospective Real-World Study Open
This retrospective observational study, building on prior research that demonstrated the efficacy of the Digital Twin (DT) Precision Treatment Program over shorter follow-up periods, aimed to examine glycemic control and reduced anti-dia…
View article: Efficacy and Safety of a Combination of Remogliflozin Etabonate and Vildagliptin as Fixed Doses in Patients with Type-2 Diabetes Mellitus: A Randomized, Active-Controlled, Double-Blind Study. (FOREVER STUDY)
Efficacy and Safety of a Combination of Remogliflozin Etabonate and Vildagliptin as Fixed Doses in Patients with Type-2 Diabetes Mellitus: A Randomized, Active-Controlled, Double-Blind Study. (FOREVER STUDY) Open
Aims: The study aimed at evaluating efficacy and safety of Remogliflozin etabonate and Vildagliptin fixed dose combination (FDC) compared to currently approved FDC of Empagliflozin and Linagliptin. Methods: A randomized, double-dummy, doub…
View article: Observational, Multicenter, Retrospective, Study on the Usage Patterns of the Fixed Dose Combination of Glimepiride, Metformin, and Voglibose in Type 2 Diabetes Management
Observational, Multicenter, Retrospective, Study on the Usage Patterns of the Fixed Dose Combination of Glimepiride, Metformin, and Voglibose in Type 2 Diabetes Management Open
View article: Table of contents
Table of contents Open
View article: FRI622 Impact Of Personalized Diet Using Digital Twin On Body Composition Parameters: 180 Day Analysis Of 209 Participants
FRI622 Impact Of Personalized Diet Using Digital Twin On Body Composition Parameters: 180 Day Analysis Of 209 Participants Open
Disclosure: P. Shamanna: None. J. Mohammed: None. M. Mohamed: None. T. Poon: None. M. Dharmalingam: None. B. Saboo: None. S. Damodharan: None. A. Vadavi: None. M. Thajudeen: None. A. Keshavamurthy: None. S. Bhonsley: None. B. R: None. S. J…
View article: FRI655 Impact Of Digital Twin Intervention On Visceral Fat And Glycemic Control In T2dm With Different Levels Of Visceral Fat
FRI655 Impact Of Digital Twin Intervention On Visceral Fat And Glycemic Control In T2dm With Different Levels Of Visceral Fat Open
Disclosure: S.R. Joshi: None. J. Mohammed: None. M. Mohamed: None. T. Poon: None. M. Dharmalingam: None. B. Saboo: None. S. Damodharan: None. A. Vadavi: None. M. Thajudeen: None. A. Keshavamurthy: None. S. Bhonsley: None. B. R: None. P. Sh…
View article: Digital Twin-Enabled Personalized Nutrition Improves Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes: Results of a 1-Year Randomized Controlled Study
Digital Twin-Enabled Personalized Nutrition Improves Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes: Results of a 1-Year Randomized Controlled Study Open
At 1 year, DT-enabled personalized treatment significantly improved hyperglycemia and surrogate markers of MAFLD and MRI-PDFF.
View article: Digital Twin Intervention for Type 2 Diabetes: One-Year Outcomes of a Randomized Trial
Digital Twin Intervention for Type 2 Diabetes: One-Year Outcomes of a Randomized Trial Open
View article: LBSUN149 Effectiveness Of Digital Twin Technology For The Improvement In Depression Among Patients Undergoing Remission Of Diabetes
LBSUN149 Effectiveness Of Digital Twin Technology For The Improvement In Depression Among Patients Undergoing Remission Of Diabetes Open
Introduction Twin Precision Treatment (TPT): a novel whole-body digital twin enabled precision nutrition that utilises 174 health markers and 3000 daily data points from blood tests and connected devices that measure weight, physical activ…
View article: PSUN230 Concordance between HbA1c, eA1C and fasting plasma glucose criteria to define type 2 diabetes remission: Insights from the Six months of Digital Twin Intervention Trial
PSUN230 Concordance between HbA1c, eA1C and fasting plasma glucose criteria to define type 2 diabetes remission: Insights from the Six months of Digital Twin Intervention Trial Open
Introduction Twin Precision Treatment (TPT): a novel whole-body digital twin enabled precision nutrition that utilises 174 health markers and 3000 daily data points from blood tests and connected devices that measure weight, physical activ…
View article: Remission of T2DM by digital twin technology with reduction of cardiovascular risk: interim results of randomised controlled clinical trial
Remission of T2DM by digital twin technology with reduction of cardiovascular risk: interim results of randomised controlled clinical trial Open
Funding Acknowledgements Type of funding sources: Private company. Main funding source(s): TWIN HEALTH INC Background Twin Precision Treatment (TPT) is a novel intervention designed to improve glycemia and reverse T2D using a Whole-Body Di…
View article: Abstract #1088834: Health Economic Analysis of Digital Twin Technology for Remission of Diabetes - Initial Insights From the Prospective Randomised Controlled Clinical Trial
Abstract #1088834: Health Economic Analysis of Digital Twin Technology for Remission of Diabetes - Initial Insights From the Prospective Randomised Controlled Clinical Trial Open
View article: Type 2 diabetes reversal with digital twin technology-enabled precision nutrition and staging of reversal: a retrospective cohort study
Type 2 diabetes reversal with digital twin technology-enabled precision nutrition and staging of reversal: a retrospective cohort study Open
View article: Retrospective study of glycemic variability, BMI, and blood pressure in diabetes patients in the Digital Twin Precision Treatment Program
Retrospective study of glycemic variability, BMI, and blood pressure in diabetes patients in the Digital Twin Precision Treatment Program Open
The objective of this retrospective observational cohort study was to measure glycemic variability and reductions in body mass index (BMI), blood pressure (BP), and use of antihypertensive medications in type 2 diabetes (T2D) patients part…
View article: Clinical data analysis of telmisartan for hypertension management in Indian population
Clinical data analysis of telmisartan for hypertension management in Indian population Open
It is of interest to evaluate the clinical characteristics, treatment patterns, clinical effectiveness, and safety of telmisartan as a monotherapy or as part of combination therapy in Indian adults (>18 years old) with hypertension. All pa…
View article: Response to Twin Enabled Precision Treatment for Reversing Diabetes: An Initial Analysis at 4 Weeks of the Ongoing Randomised Controlled Trial
Response to Twin Enabled Precision Treatment for Reversing Diabetes: An Initial Analysis at 4 Weeks of the Ongoing Randomised Controlled Trial Open
Introduction: Technology enabled precision nutrition, a combination of macro, micro and biota nutrients, along with Continuous Glucose Monitoring (CGM) have been demonstrated to be a key for reversal of diabetes. Methods: We conducted an i…
View article: Combined improvement of insulin resistance and hypertension using whole body digital twin technology in diabetic hypertensives- a real world study
Combined improvement of insulin resistance and hypertension using whole body digital twin technology in diabetic hypertensives- a real world study Open
Funding Acknowledgements Type of funding sources: Private company. Main funding source(s): Twin Health OnBehalf TWIN Study Group Introduction Insulin resistance is multifaceted phenomenon that affects blood pressure homeostasis Methods 207…
View article: Evaluation of acute oral toxicity ofmethanolic fractions of Sesbania grandiflora Linn. roots in albino mice
Evaluation of acute oral toxicity ofmethanolic fractions of Sesbania grandiflora Linn. roots in albino mice Open
Introduction: Although Sesbania grandiflora Linn. roots have valuable pharmacological effects, the comprehensive awareness about its toxicity potential has been lacking. Objectives: The objectives of the study were to assess the acute oral…
View article: Reducing HbA1c in Type 2 Diabetes Using Digital Twin Technology-Enabled Precision Nutrition: A Retrospective Analysis
Reducing HbA1c in Type 2 Diabetes Using Digital Twin Technology-Enabled Precision Nutrition: A Retrospective Analysis Open
View article: Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial
Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial Open
CTRI/2017/07/009121.